Zeliha Guler (Amsterdam UMC): Development of a novel wound-healing implant with localized estradiol delivery
One out of four women is under risk for prolapse, and it increases up to 60% by age or giving birth. For the correction of prolapse permanent implants are being used, but they may cause clinical complications in the long term. A newly developed degradable implant can eliminate clinical complications, in combination with the electrospinning technique, provides the natural structures for the cells and tissues to interact with. By addition of estradiol into implants, the healing and regeneration of the pelvic tissues is further improved. The technology may lead to a groundbreaking solution for prolapse treatment and could benefit a large patient population and clinicians.
Imran Avci (VU): Disposable, ultra-sensitive optical biosensors for early cancer diagnosis (COMB-O) In the last decade, cancer has become a silent pandemic as it is the second leading cause of death globally. Early diagnosis is critical for successful treatment, and therefore we urgently need sensitive, specific and affordable solutions. The development of optical biosensors that […]
Marjon van Rijn (HvA): Journey to the end of life Research indicates that healthcare professionals often struggle to initiate conversations about the wishes and preferences for care and treatment at the end of life with older people. A partial solution lies in providing training for these discussions within a safe learning environment by way of […]
Ewelina Weglarz-Tomczak (UvA): Novel lysosomal protease inhibitors for the treatment of Alzheimer’s disease Highly specified proteases are the key regulators in the molecular mechanism of neurodegeneration in Alzheimer’s disease. AI-powered technology developed by NatInLab has led to the discovery of how those proteases are controlled in the human organism. Based on this knowledge, developing novel, […]